Table 3 A comprehensive comparison of various pathological characteristics between the groups exhibiting lymphatic leakage and those without
characteristics | Lymphatic leakage | No lymphatic leakage | P-value |
|---|---|---|---|
T stage, n (%) | 0.247 | ||
T2 | 164 (50.5%) | 161 (49.5%) | |
T3 | 48 (42.9%) | 64 (57.1%) | |
T4 | 42 (43.3%) | 55 (56.7%) | |
N stage, n (%) | 0.920 | ||
Nx | 12 (50.0%) | 12 (50.0%) | |
N0 | 196 (47.2%) | 219 (52.8%) | |
N1 | 24 (44.4%) | 30 (55.6%) | |
N2 | 19 (54.3%) | 16 (45.7%) | |
N3 | 3 (50%) | 3 (50%) | |
Histological type, n (%) | 0.139 | ||
Urothelial carcinoma | 236 (48.7%) | 249 (51.3%) | |
Adenocarcinoma | 1 (11.1%) | 8 (88.9%) | |
Squamous carcinoma | 1 (50%) | 1 (50%) | |
Others | 16 (42.1%) | 22 (57.9%) | |
Tumor grade, n (%) | 0.223 | ||
High-grade urothelial carcinoma | 176 (47.4%) | 195 (52.6%) | |
Low grade urothelial carcinoma | 17 (40.5%) | 25 (59.5%) | |
PUNLMP | 2 (100%) | 0 (0%) | |
Number of lymph nodes dissected, median (IQR) | 11 (6, 15.75) | 8 (4, 14) | < 0.001 |
Number of positive lymph nodes, median (IQR) | 2 (1, 3) | 2 (1, 3) | 0.676 |
Incisal margin, n (%) | 0.874 | ||
negative | 216 (47.5%) | 239 (52.5%) | |
positive | 18 (46.2%) | 21 (53.8%) |